263 related articles for article (PubMed ID: 28249651)
1. Symptom burden and dysphagia associated with osteoradionecrosis in long-term oropharynx cancer survivors: A cohort analysis.
Wong ATT; Lai SY; Gunn GB; Beadle BM; Fuller CD; Barrow MP; Hofstede TM; Chambers MS; Sturgis EM; Mohamed ASR; Lewin JS; Hutcheson KA
Oral Oncol; 2017 Mar; 66():75-80. PubMed ID: 28249651
[TBL] [Abstract][Full Text] [Related]
2. Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: Comparison of patient-reported outcome measures of swallowing.
; Grant S; Kamal M; Mohamed ASR; Zaveri J; Barrow MP; Gunn GB; Lai SY; Lewin JS; Rosenthal DI; Wang XS; Fuller CD; Hutcheson KA
Cancer; 2019 May; 125(10):1654-1664. PubMed ID: 30633325
[TBL] [Abstract][Full Text] [Related]
3. The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience.
Owosho AA; Tsai CJ; Lee RS; Freymiller H; Kadempour A; Varthis S; Sax AZ; Rosen EB; Yom SK; Randazzo J; Drill E; Riedel E; Patel S; Lee NY; Huryn JM; Estilo CL
Oral Oncol; 2017 Jan; 64():44-51. PubMed ID: 28024723
[TBL] [Abstract][Full Text] [Related]
4. Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy.
Caparrotti F; Huang SH; Lu L; Bratman SV; Ringash J; Bayley A; Cho J; Giuliani M; Kim J; Waldron J; Hansen A; Tong L; Xu W; O'Sullivan B; Wood R; Goldstein D; Hope A
Cancer; 2017 Oct; 123(19):3691-3700. PubMed ID: 28608925
[TBL] [Abstract][Full Text] [Related]
5. Symptom Burden Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Cancer Survivors.
Aggarwal P; Zaveri JS; Goepfert RP; Shi Q; Du XL; Swartz M; Gunn GB; Lai SY; Fuller CD; Hanna EY; Rosenthal DI; Lewin JS; Piller LB; Hutcheson KA
JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1066-1076. PubMed ID: 30193299
[TBL] [Abstract][Full Text] [Related]
6. Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: Results from a case-matched comparison.
MD Anderson Head and Neck Cancer Symptom Working Group
Radiother Oncol; 2017 Aug; 124(2):232-239. PubMed ID: 28733053
[TBL] [Abstract][Full Text] [Related]
7. Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old.
; Eraj SA; Jomaa MK; Rock CD; Mohamed ASR; Smith BD; Smith JB; Browne T; Cooksey LC; Williams B; Temple B; Preston KE; Aymard JM; Gross ND; Weber RS; Hessel AC; Ferrarotto R; Phan J; Sturgis EM; Hanna EY; Frank SJ; Morrison WH; Goepfert RP; Lai SY; Rosenthal DI; Mendoza TR; Cleeland CS; Hutcheson KA; Fuller CD; Garden AS; Gunn GB
Radiat Oncol; 2017 Sep; 12(1):150. PubMed ID: 28888224
[TBL] [Abstract][Full Text] [Related]
8. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma.
Goepfert RP; Lewin JS; Barrow MP; Fuller CD; Lai SY; Song J; Hobbs BP; Gunn GB; Beadle BM; Rosenthal DI; Garden AS; Kies MS; Papadimitrakopoulou VA; Schwartz DL; Hutcheson KA
Laryngoscope; 2017 Apr; 127(4):842-848. PubMed ID: 27440393
[TBL] [Abstract][Full Text] [Related]
9. Modern Image-Guided Intensity-Modulated Radiotherapy for Oropharynx Cancer and Severe Late Toxic Effects: Implications for Clinical Trial Design.
Ward MC; Ross RB; Koyfman SA; Lorenz R; Lamarre ED; Scharpf J; Burkey BB; Joshi NP; Woody NM; Prendes B; Houston N; Reddy CA; Greskovich JF; Adelstein DJ
JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1164-1170. PubMed ID: 27438230
[TBL] [Abstract][Full Text] [Related]
10. Adhering to Eat and Exercise Status During Radiotherapy for Oropharyngeal Cancer for Prevention and Mitigation of Radiotherapy-Associated Dysphagia.
Barbon CEA; Peterson CB; Moreno AC; Lai SY; Reddy JP; Sahli A; Martino R; Johnson FM; Fuller CD; Hutcheson KA
JAMA Otolaryngol Head Neck Surg; 2022 Oct; 148(10):956-964. PubMed ID: 36074459
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy dose-volume parameters predict videofluoroscopy-detected dysphagia per DIGEST after IMRT for oropharyngeal cancer: Results of a prospective registry.
Kamal M; Mohamed ASR; Volpe S; Zaveri J; Barrow MP; Gunn GB; Lai SY; Ferrarotto R; Lewin JS; Rosenthal DI; Jethanandani A; Meheissen MAM; Mulder SL; Cardenas CE; Fuller CD; Hutcheson KA;
Radiother Oncol; 2018 Sep; 128(3):442-451. PubMed ID: 29961581
[TBL] [Abstract][Full Text] [Related]
12. Impact of selective neck dissection on chronic dysphagia after chemo-intensity-modulated radiotherapy for oropharyngeal carcinoma.
Hutcheson KA; Abualsamh AR; Sosa A; Weber RS; Beadle BM; Sturgis EM; Lewin JS
Head Neck; 2016 Jun; 38(6):886-93. PubMed ID: 26339764
[TBL] [Abstract][Full Text] [Related]
13. Self-reported oral morbidities in long-term oropharyngeal cancer survivors: A cross-sectional survey of 906 survivors.
MD Anderson Head and Neck Cancer Symptom Working Group
Oral Oncol; 2018 Sep; 84():88-94. PubMed ID: 30115482
[TBL] [Abstract][Full Text] [Related]
14. Persistent dysphagia after head and neck radiotherapy: a common and under-reported complication with significant effect on non-cancer-related mortality.
Szczesniak MM; Maclean J; Zhang T; Graham PH; Cook IJ
Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):697-703. PubMed ID: 25239671
[TBL] [Abstract][Full Text] [Related]
15. Long-term quality of life after swallowing and salivary-sparing chemo-intensity modulated radiation therapy in survivors of human papillomavirus-related oropharyngeal cancer.
Vainshtein JM; Moon DH; Feng FY; Chepeha DB; Eisbruch A; Stenmark MH
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):925-33. PubMed ID: 25832685
[TBL] [Abstract][Full Text] [Related]
16. Contribution of submandibular gland and swallowing structure sparing to post-radiation therapy PEG dependence in oropharynx cancer patients treated with split-neck IMRT technique.
Gensheimer MF; Nyflot M; Laramore GE; Liao JJ; Parvathaneni U
Radiat Oncol; 2016 Nov; 11(1):151. PubMed ID: 27846899
[TBL] [Abstract][Full Text] [Related]
17. Modeling symptom drivers of oral intake in long-term head and neck cancer survivors.
Kamal M; Barrow MP; Lewin JS; Estrella A; Gunn GB; Shi Q; Hofstede TM; Rosenthal DI; Fuller CD; Hutcheson KA;
Support Care Cancer; 2019 Apr; 27(4):1405-1415. PubMed ID: 30218187
[TBL] [Abstract][Full Text] [Related]
18. Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlations.
Aarup-Kristensen S; Hansen CR; Forner L; Brink C; Eriksen JG; Johansen J
Acta Oncol; 2019 Oct; 58(10):1373-1377. PubMed ID: 31364903
[No Abstract] [Full Text] [Related]
19. Potential risk factors for jaw osteoradionecrosis after radiotherapy for head and neck cancer.
Kuhnt T; Stang A; Wienke A; Vordermark D; Schweyen R; Hey J
Radiat Oncol; 2016 Jul; 11():101. PubMed ID: 27473433
[TBL] [Abstract][Full Text] [Related]
20. Aspiration pneumonia after chemo-intensity-modulated radiation therapy of oropharyngeal carcinoma and its clinical and dysphagia-related predictors.
Hunter KU; Lee OE; Lyden TH; Haxer MJ; Feng FY; Schipper M; Worden F; Prince ME; McLean SA; Wolf GT; Bradford CR; Chepeha DB; Eisbruch A
Head Neck; 2014 Jan; 36(1):120-5. PubMed ID: 23729173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
